It has become clear that as neuroectodermal stem cells evaginate from the oral primordia and migrate superiorly to join peptidergic neurons of the posterior pituitary, that transcription activators and repressors are likely to interact in order to establish various and discrete cell types that comprise the anterior pituitary gland. Our understanding of the molecular details which dictate the tissue-restricted expression of pituitary-specific genes has been advanced by the discovery of pit-1/GHF- 1, a pituitary-specific transcription factor which contains a POU- homeodomain and regulates the promoter activity of the growth hormone (GH), prolactin (PRL), and Pit-1/GHF-1 genes. Pit-1 serves not only as a transcription activator of these genes, but it also plays a critical role as a differentiation factor, specifying the ontogeny of the somatotroph, lactotroph, and thyrotroph pituitary cell lineages. Nevertheless, the presence or absence of a tissue-specific transcription activator, such as Pit-1/GHF-1, cannot account for the 7 to 8 orders of magnitude of differential GH and PRL gene expression between pituitary and nonpituitary tissues. The achievement of such high levels of tissue-restricted gene expression implies that repressors of GH and PRL gene expression must be present in nonpituitary cell types. We have discovered the presence of a repressor of rPRL promoter activity in nonpituitary cell types, and of a ubiquitous trans-activator required for basal rPRL promoter activity, and we have mapped the rPRL DNA elements to which they bind. The repressor, termed F2F, binds to the footprint (FP) II site, and it appears to functionally interfere with the basal activating function of the vicinally-bound BTF, which binds to the basal transcription element, or BTE. Our data suggests a model whereby the inhibitory effect of F2F is dependent on the BTE DNA context and, therefore, the DNA-binding of BTF. Furthermore, these factors appear to modulate the hormonal response of the rPRL promoter; most likely by influencing Pit-1 bound to the most proximal cell-specific element.
The Specific Aims we propose in order to test this model directly, are: (1) to fully characterize the F2F/FP II and BTF/BTE protein DNA interactions; (2) to functionally dissect the FP II and BTE DNA elements; (3) to determine mechanism by which F2F and/or BTF modulate hormonal control of the rPRL promoter; (4) to purify F2F and BTF; and (5) to clone cDNAs for F2F and BTF. The significance of these studies is that they will fully elucidate the precise molecular mechanism(s) by which ubiquitous factors govern the activity of a highly tissue-restricted gene. Since there is little understanding of the fundamental processes by which ubiquitous factors influence tissue-specific gene expression, these studies are very likely to provide novel insights into the molecular mechanisms by which the basal transcription machinery governs tissue- specific gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037667-11
Application #
2608410
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1986-07-01
Project End
1998-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Tong, Yunguang; Zhou, Jin; Mizutani, Jun et al. (2011) CEBPD suppresses prolactin expression and prolactinoma cell proliferation. Mol Endocrinol 25:1880-91
Jonsen, Matthew D; Duval, Dawn L; Gutierrez-Hartmann, Arthur (2009) The 26-amino acid ss-motif of the Pit-1ss transcription factor is a dominant and independent repressor domain. Mol Endocrinol 23:1371-84
Jedlicka, Paul; Sui, Xiaomei; Gutierrez-Hartmann, Arthur (2009) The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer 9:197
Jedlicka, Paul; Sui, Xiaomei; Sussel, Lori et al. (2009) Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine. Am J Pathol 174:1280-90
Jedlicka, Paul; Gutierrez-Hartmann, Arthur (2008) Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 23:1417-24
Ferry, A L; Locasto, D M; Meszaros, L B et al. (2005) Pit-1beta reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner. J Endocrinol 185:173-85
Farrow, Kathryn N; Bradford, Andrew P; Tentler, John J et al. (2004) Structural and functional analysis of the differential effects of c-Jun and v-Jun on prolactin gene expression. Mol Endocrinol 18:2479-90
Dunkelberg, J C; Gutierrez-Hartmann, A (2001) LZ-FYVE: a novel developmental stage-specific leucine zipper, FYVE-finger protein. DNA Cell Biol 20:403-12
Diamond, S E; Gutierrez-Hartmann, A (2000) The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. J Biol Chem 275:30977-86
Farrow, K N; Gutierrez-Hartmann, A (1999) Transforming growth factor-beta1 inhibits rat prolactin promoter activity in GH4 neuroendocrine cells. DNA Cell Biol 18:863-73

Showing the most recent 10 out of 35 publications